Sintx Technologies, Inc.
No enriched coverage for $SINT in the last 7 days.
No SEC Form 4 filings for $SINT in the last 30 days.
See all $SINT insider activity →SINTX Technologies received $2.01M from exercised Class B warrants, issuing 651,204 shares. The call period ended Oct 8, 2026. No Class B warrants remain outstanding, and Class A warrants were unaffected.
Sintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. On October 1, 2026, SINTX Technologies, Inc. (the “Company”) delivered call notices to holders of its outstanding Class B Common Stock Purchase Warrants pursuant to the call provisions described in the Company’s Current Report on Form 8-K furnished that d
SinterCast reported Q3 2026 series production up 19% YoY to 3.25M annualized Engine Equivalents, with September at 3.8M. Sampling Cup shipments rose 80% YoY, suggesting increased CGI foundry activity. The company sees this as a mid-cycle recovery confirmation.
Recent SINT coverage spans earnings, corporate actions and financial news.
Warrant exercises and share issuance reduce remaining Class B warrant overhang (now none outstanding) and bring in modest cash, which can slightly support liquidity but is dilutive.
Warrant call and expiration remove overhang from Class B warrants and increase common shares outstanding via exercised funded exchanges.
Higher production suggests improved demand and revenue potential.
Revenue beat suggests improved demand and potential warrant exercise, likely supporting the stock.
Ascendiant Capital maintained a Buy rating on SINTX Technologies with a $12.50 price target, implying 460.5% upside from the Sep 30 close of $2.23. The firm cited strong growth potential in the orthopedic device market and attractive valuation.
AlphAI scores every news story that mentions SINT with an AI model for sentiment and relevance, and aggregates insider trades from Sintx Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
SINTX Technologies received $2.01M from exercised Class B warrants, issuing 651,204 shares. The call period ended Oct 8, 2026. No Class B warrants remain outstanding, and Class A warrants were unaffected.
1 min readSintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. On October 1, 2026, SINTX Technologies, Inc. (the “Company”) delivered call notices to holders of its outstanding Class B Common Stock Purchase Warrants pursuant to the call provisions described in the Company’s Current Report on Form 8-K furnished that d
3 min readSinterCast reported Q3 2026 series production up 19% YoY to 3.25M annualized Engine Equivalents, with September at 3.8M. Sampling Cup shipments rose 80% YoY, suggesting increased CGI foundry activity. The company sees this as a mid-cycle recovery confirmation.
1 min readSINTX Technologies reported preliminary Q3 revenue of $2.2M, exceeding guidance of $0.9M-$1.1M, driven by industrial sales. Revenue grew 380% from Q2. The company reiterated Q4 guidance and plans to call Class B warrants, potentially raising up to $4.0M in capital.
2 min readAscendiant Capital maintained a Buy rating on SINTX Technologies with a $12.50 price target, implying 460.5% upside from the Sep 30 close of $2.23. The firm cited strong growth potential in the orthopedic device market and attractive valuation.
1 min readSintx Technologies reported a Q2 2026 transition toward a commercial biomaterials and medical technology platform. Revenue rose 199% on OEM industrial demand and pricing, with gross margin near 62%. Management cited a $3.2M backlog to convert into revenue, SiNAPTIC wedge first clinical use in March 2026, and Q3/Q4 revenue guidance of $0.9M-$1.1M and $1.0M-$1.3M, while noting going-concern financing needs.
6 min readSintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives SALT LAKE CITY, Utah – August 11, 2026 – SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a
2 min readSintx Technologies, Inc. (SINT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER T
3 min readSyntiant Corp. said it appointed Adam Spice, CFO of Rocket Lab (Nasdaq: RKLB), and David Lam, CIO of Lam Frontier Technologies, to its board. The company cited Spice’s 25+ years of aerospace/technology finance leadership and Lam’s 25+ years investing in semiconductors and AI. Syntiant said the appointments support its growth and investor engagement.
2 min readMaxim Group reiterated a “Buy” rating on Sintx Technologies (NASDAQ:SINT) and set a $6.00 price target, implying 169.66% upside from the prior close, according to Benzinga. Other firms cited include Ascendiant (cut target to $12, Buy), Weiss (sell), and HC Wainwright (Buy, $10). SINT last traded at $2.23. The company reported Q EPS of ($0.70) vs ($0.66) consensus and revenue of $0.38M vs $0.30M.
4 min read
